微针辅助局部药物治疗黄褐斑的系统评价与荟萃分析
该系统评价与荟萃分析纳入12项前瞻性对照研究共459例患者,评估微针辅助局部药物治疗黄褐斑的疗效。结果显示微针辅助局部治疗在8周后大幅改善黄褐斑严重程度,12周效果最佳;与单用局部治疗相比,8周时中等效果、12-16周时大幅效果,且耐受性良好,无严重不良事件。
要点
- 微针辅助局部治疗在8周后大幅改善黄褐斑严重程度,12周效果最佳。
- 与单用局部治疗相比,联合微针在8周时中等效果、12-16周时大幅效果。
- 微针耐受性良好,研究间无严重不良事件报告。
核心结论
- 微针是局部药物治疗黄褐斑的有效辅助手段。
研究设计与样本
- 遵循PRISMA指南的系统评价与荟萃分析,纳入12项前瞻性对照研究共459例患者,来自7个国家。
- 纳入局部干预联合微针治疗黄褐斑的对照研究,排除涉及射频微针的研究。
主要发现
- 局部治疗联合微针在8周后大幅改善黄褐斑严重程度(标准化均数差>0.8),12周效果最佳。
- 与单用局部治疗相比,联合微针在8周时中等效果、12-16周时大幅效果。
- 微针在各研究中耐受性良好,无严重不良事件报告。
关键数值与推荐
- 局部治疗包括局部氨甲环酸、维生素C、富血小板血浆、非氢醌类脱色精华和氢醌类脱色剂。
- 微针辅助局部治疗改善黄褐斑严重程度的标准化均数差>0.8(大幅效果,8周后)。
临床怎么用
- 可将微针作为局部药物治疗黄褐斑的辅助手段,尤其关注12周左右的疗效。
- 联合微针在8周时中等效果、12-16周时大幅效果,可作为疗程规划的参考。
局限性
- 研究设计异质性大,无法比较不同局部治疗联合微针的疗效差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microneedling as an adjuvant to topical medications has shown promising but variable results in the treatment of melasma. OBJECTIVE: To conduct a systematic review and meta-analysis on the efficacy of microneedling as an adjuvant to topical therapies for the treatment of melasma. METHODS: This study followed PRISMA guidelines. All comparative, prospective studies on the use of topical interventions with microneedling for the treatment of melasma were included. Studies involving radiofrequency microneedling were excluded. RESULTS: Twelve eligible studies comprising 459 patients from 7 different countries were included. Topical therapies included topical tranexamic acid, vitamin C, platelet-rich plasma, non-hydroquinone-based depigmentation serums, and hydroquinone-based depigmenting agents. Topical therapy with microneedling improved melasma severity with a large effect (standardized mean difference >0.8) beyond 8 weeks, with best results seen at 12 weeks. Compared to topical therapy alone, topical therapy with microneedling resulted in an additional improvement in melasma severity with a moderate effect at 8 weeks and a large effect at 12-16 weeks. Microneedling was well tolerated across studies, with no serious adverse events reported. LIMITATIONS: Heterogeneity in study designs did not allow for a comparison of the efficacy of various topical therapies with microneedling. CONCLUSION: Microneedling is useful adjuvant to topical therapies for the treatment of melasma.
引用
- Bailey AJM, Li HO, Tan MG, et al. Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis. J Am Acad Dermatol. 2021. PMID: 33857549. doi:10.1016/j.jaad.2021.03.116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。